REG - Thruvision Group PLC - Sharesave option grant to Executive Director

ThruvisionAnnouncement

03/02/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230203:nRSC8035Oa&default-theme=true

RNS Number : 8035O  Thruvision Group PLC  03 February 2023

 

3 February 2023

Thruvision Group plc

 

("Thruvision" or the "Group")

 

Sharesave option grant to Executive Director

 

Thruvision (AIM:THRU), the leading provider of "safe distance"
people-screening technology to the international security market announces a
grant of share options under the Thruvision Sharesave Scheme (the "Scheme").

 

The Remuneration Committee of the Group have granted, under the rules of the
Scheme, an option over 81,447 Ordinary 1p shares with an exercise price of
17.68 pence per share to Victoria Balchin.

 

The exercise price, set on 11 January 2023, is calculated on the basis of 80%
of the closing middle market price of Thruvision shares on 11 January 2023.
The option may be exercised between 1 March 2026 and 31 August 2026, assuming
the conditions of the Scheme are met.

 

The notifications below, made in accordance with the requirements of the EU
Market Abuse Regulation, provides further detail:

 

 1.   Details of the person discharging managerial responsibilities/person closely
      associated
 (a)  Name                                             Victoria Balchin
 2.   Reason for the notification
 (a)  Position/status                                  Chief Financial Officer
 (b)  Initial notification/ Amendment                  Initial notification
 3.   Details of the issuer
 (a)  Name                                             Thruvision Group plc
 (b)  LEI                                              213800IZG9GM6G2TZE04
 4.   Details of the transaction(s): section to be repeated for (i) each type of
      instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted
 (a)  Description of the Financial Instrument          Ordinary shares of £0.01 each
 (b)  Identification code of the Financial Instrument  GB00B627R876
 (c)  Nature of the transaction                        Grant of Options under the Sharesave Scheme.

 (d)  Price(s) and volume(s)                           Price(s)                    Volume(s)
                                                       17.68p                      81,447

 (e)  Aggregated information                           N/A

      -           Aggregated volume

      -           Price
 (f)  Date of the transaction                          3 February 2023
 (g)  Place of the transaction                         Not a trading venue

 

 

 

 

 

For further information please contact:

 

Thruvision Group
plc
+44 (0)1235 425400

Tom Black, Executive Chairman

Colin Evans, Chief Executive

 

Investec Investment Banking (NOMAD & Broker)
  +44 (0)20 7597 5970

Patrick Robb / James Rudd / Sebastian Lawrence

 

FTI Consulting
LLP
+44 (0)20 3727 1000

Matt Dixon

 

About Thruvision

Addressing the urgent need for "safe distance" people security screening in
the COVID era, Thruvision is uniquely capable of detecting metallic and
non-metallic items including weapons, explosives and contraband items that are
hidden under clothing, at distances between 3 and 10m. Using patented passive
terahertz technology, Thruvision completely removes the need for physical
"pat-downs" and has been vetted and approved by the US Transportation Security
Administration for surface transportation. Operationally deployed in 20
countries around the world, Thruvision is used for aviation security, retail
supply chain loss prevention, customs and border control, and public area
security. The company has offices near Oxford, and Washington DC.

 

 

www.thruvision.com (http://www.thruvision.com)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHFLFFTFTIFIIV